Get started
Author

Shailendra Singh

Observed name: Shailendra R. Singh
ORCID: 0000-0001-7675-6523
Observed ORCID: 0000-0001-7675-6523
OpenAlex ID: A5047690205
Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents
2020 · Shailendra Singh, Chandrabose Karthikeyan, et al. · Mini-Reviews in Medicinal Chemistry · 31
Fatty Acid Synthase (FASN): A Patent Review Since 2016-Present
2023 · Shailendra Singh, Chandrabose Karthikeyan, et al. · Recent Patents on Anti-Cancer Drug Discovery · 14
Can lineage-specific markers be identified to characterize mesenchyme-derived cell populations in the human airways?
2010 · Shailendra R. Singh, Charlotte K. Billington, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 10
Design, synthesis, and anticancer activity of some novel 1H-benzo[d]imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors
2023 · Shailendra Singh, Subarno Paul, et al. · Bioorganic Chemistry · 9
Classification analysis of fatty acid synthase inhibitors using multialgorithms on topological descriptors and structural fingerprints
2022 · Shailendra Singh, Chandrabose Karthikeyan, et al. · Chemical Biology & Drug Design · 8
Design, synthesis and biological evaluation of 2-phenylquinoxaline carbonyl piperazine derivatives as novel FASN inhibitors with anticancer activity
2025 · Shailendra Singh, Subarno Paul, et al. · Bioorganic Chemistry · 1
Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives
2026 · Nikhil Rawal, Shruti Batra, et al. · Current Pharmaceutical Design
Design, Synthesis and Biological Evaluation of Novel 1H-benzo[d]imidazole Derivatives as Fatty Acid Synthase (FASN) Inhibitors for Cancer Treatment
2022 · Shailendra Singh, Subarno Paul, et al. · International Electronic Conference on Medicinal Chemistry (ECMC)
PDF
Works count: 8
Citation count: 73
H-index: 5
I10-index: 3
Year
Topic
Type